Mingfei Guo
No. 100, Huaihai Avenue
Hefei, 230041, China
Hefei, 230041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Overexpression of FTO ameliorates chronic glomerulonephritis by inhibiting glycolysis in glomerular mesangial cells associated with ADPGK m6A modification.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 23, 2026
Astragalus polysaccharide alleviates diabetic nephropathy via SIRT1-dependent activation of FOXO3a/BNIP3 pathway to enhance podocyte autophagy.
Journal: Scientific reports
Published: September 05, 2025
METTL3-mediated m6A modification of SIRT1 mRNA modulates podocyte autophagy in diabetes nephropathy with the treatment effect of Astragalus polysaccharide.
Journal: International journal of biological macromolecules
Published: July 02, 2025
Association Between Serum Folic Acid Levels and Type 2 Diabetes Mellitus in Overweight or Obese Patients: A Retrospective Study.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: March 02, 2025
METTL3-mediated m6A modification of EGR1 mRNA promotes T2DM vasculopathy.
Journal: Cellular signalling
Published: June 05, 2024
Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway.
Journal: Drug design, development and therapy
Published: March 20, 2023
Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy via Novel Biomarkers and Competing Endogenous RNA Network.
Journal: Frontiers in endocrinology
Published: May 02, 2022
Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
Journal: Medicine
Published: July 12, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026